Clinical Trials

162 enrolled

Brain Neoplasms, Central Nervous System Diseases, Glioblastoma, Glioma

NCT06861244 2026-04-13

PNOC031

70 enrolled

Neuroectodermal Tumors, Primitive, Pyloric Stenosis, Hypertrophic

NCT04919382 2026-04-08

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

56 enrolled

Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

NCT05096481 2026-04-08

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma

NCT05661643 2026-04-07

GIST

29 enrolled

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT03899155 2026-04-01

Pan Tumor Rollover Study

1,500 enrolled

Tumor-Agnostic

Neoplasms

NCT05999994 2026-03-27

CAMPFIRE

105 enrolled

Tumor-Agnostic

Neoplasms

NCT07015242 2026-03-24

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

65 enrolled

Lymphoid

Lymphoma

NCT06450041 2026-03-23

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

62 enrolled

Neuroblastoma

NCT05843253 2026-03-20

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

NCT07297212 2026-03-12

A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma

75 enrolled

Brain Neoplasms, Glioblastoma

NCT06202066 2026-03-11

Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas

Adenoma, Islet Cell

NCT05188508 2026-03-06

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

57 enrolled

Glioma

NCT05463848 2026-03-04

Surgical Pembro +/- Olaparib w TMZ for rGBM

78 enrolled

Glioblastoma

NCT07310784 2026-03-03

A Phase II Trial of LM103 in Advanced Melanoma

92 enrolled

Dermatologic

Advanced Melanoma

NCT01356290 2026-02-23

MEMMAT

232 enrolled

Ependymoma, Medulloblastoma, Recurrence

NCT06528496 2026-02-10

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

45 enrolled

Neuroblastoma

NCT05629702 2026-01-30

ARISTOCRAT

Brain Neoplasms, Marijuana Abuse, Glioblastoma, Recurrence

NCT04623931 2026-01-14

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

40 enrolled

Astrocytoma, Glioblastoma, Oligodendroglioma

NCT06991101 2025-12-26

Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma

190 enrolled

Brain Neoplasms, Glioblastoma

NCT06703398 2025-12-23

MIZAR-003

98 enrolled

Dermatologic

Melanoma

NCT05040360 2025-12-15

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

141 enrolled

Adenoma, Islet Cell

NCT04339036 2025-12-10

CapTemY90

70 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT04945148 2025-11-21

OPTIMUM

640 enrolled

Glioblastoma

NCT05052957 2025-11-21

hSTAR GBM

16 enrolled

Glioblastoma

NCT02977780 2025-11-10

INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)

460 enrolled

Glioblastoma

NCT06617923 2025-10-27

Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer

18 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT07193654 2025-09-26

Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread

38 enrolled

Glioblastoma, Meningeal Carcinomatosis

NCT06649851 2025-09-25

G-CSF After Chemo-radiation in Patients With Glioblastoma

Glioblastoma

NCT06023641 2025-08-19

Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease

135 enrolled

Sarcoma

Rhabdomyosarcoma

NCT04523688 2025-07-22

Combi G-Vax

28 enrolled

Glioblastoma

NCT06013618 2025-06-17

Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma

Neuroblastoma

NCT04566380 2025-06-03

ONO-4538 Phase II Rollover Study (ONO-4538-98)

59 enrolled

Pan-tumor

NCT06827717 2025-05-31

Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma

29 enrolled

Sarcoma

Sarcoma, Ewing

NCT05512481 2025-03-03

Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma

Dermatologic

Melanoma

NCT06161974 2025-02-21

Study of Olutasidenib and Temozolomide in HGG

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Spinal Cord Neoplasms

NCT06739395 2024-12-18

Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion

300 enrolled

Other solid neoplasm

Solid Tumor

NCT05554003 2024-11-18

MeTe

46 enrolled

EndocrineNET

Frailty, Neuroendocrine Tumors

NCT04501718 2024-10-15

Apatinib Combined with Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Children

44 enrolled

Medulloblastoma

NCT06595186 2024-09-19

JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)

25 enrolled

Glioblastoma

NCT04893785 2024-06-18

CABOTEM

EndocrineGastrointestinalNET

35 enrolled

Gastro-enteropancreatic neuroendocrine tumor

NCT06297512 2024-03-07

Evaluate the Role of Anthracycline After Radio Therapy in Patients With Glioblastoma (pGBM).

20 enrolled

Glioblastoma

NCT04984733 2023-11-29

ELEVATE

18 enrolled

Gastrointestinal

Esophageal Neoplasms, Neoplasms

NCT05136326 2023-03-01

CATARTIC